Kembali ke Pencarian
2026 Artikel Jurnal Scopus/WOS Terdampak Faktor (SSCI,SCIE,SCI) B.3 - (Q3) <0,5 Selesai

Nutritional Composition of Fermented Buffalo Milk and its Effect on Blood Pressure in Diabetic Rattus Novergicus Models

MJMHS Dessy Abdullah

Penulis / Author

1
Dessy Abdullah (Universitas Baiturrahmah) Utama
2
Nadia Purnama Dewi (Universitas Baiturrahmah)
3
Yudha pratama (Pusat probiotik)

Detail Publikasi

MJMHS

Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM)

9

mjmhs.22.s9.35

32-239

1675-8544

Abstrak

Introduction: This study investigated the nutritional composition and cardiovascular health benefits of fermented buffalo milk (Dadiah), focusing on its effects on blood pressure, blood glucose, cholesterol, and the expression of ACE2 and COX-2 in experimental animals. ACE2 plays a key role in regulating blood pressure and cardiovascular health, while COX-2 is associated with inflammation and blood vessel function. Methods: The experimental study employed a complete randomized design (CRD) involving white Wistar rats divided into four groups: Negative Control, Positive Control, Fermented Buffalo Milk, and Ramipril treatment, with treatments lasting 8 weeks. Blood pressure was measured non-invasively, glucose and cholesterol biochemically, and ACE2 and COX-2 expressions via immunohistochemistry. Statistical analysis was performed using one-way ANOVA. Results: Fermented buffalo milk from Limapuluh Kota Regency was found to contain 78.33% moisture, 7.97% protein, 6.53% fat, and a total LAB count of 67x10⁹ CFU/g. Compared to the Positive Control group, the milk significantly reduced blood pressure, blood glucose, and cholesterol. Both the milk and Ramipril groups suppressed ACE2 expression, with the milk showing effects comparable to Ramipril. COX-2 expression was also significantly lower in these groups. Conclusion: The findings suggest fermented buffalo milk may serve as an alternative to Ramipril for controlling hypertension, while also benefiting blood glucose and cholesterol regulation through ACE2 and COX-2 pathway modulation. Further clinical studies are recommended to confirm these results in humans.

Dana Insentif

B.3 - (Q3) <0,5

Rp 15.000.000

Dana Disetujui

Rp 15.000.000

Dicairkan

04 Nov 2026

Alur Proses

Klaim Diajukan

10 Sep 2026

Verifikasi Fakultas

10 Sep 2026

Verifikasi Rektorat

12 Oct 2026

Verifikasi Sekretaris

17 Sep 2026

Disetujui Ka LPPM

23 Sep 2026

Dana Dicairkan

04 Nov 2026
Status Saat Ini Selesai

Informasi Dosen

DA

Dessy Abdullah

NIDN: 1012127604

Lektor Kepala

Fakultas Fakultas Kedokteran
Prodi Pendidikan Dokter
... online